1 February 2010 in Clinical Immunology
14 August 2023 in BMC Infectious Diseases
Background: The geographical distribution of hepatitis B virus (HBV) and hepatitis D virus (HDV) genotypes is uneven and has its own clinical and organizational implications for health systems. Despite the introduction of vaccination and successful antiviral therapy the prevalence of chronic hepatitis B (with or without delta agent) increased over the past 5 years. This study aimed for the first time to investigate the molecular epidemiology of HBV and HDV in Kazakhstan. Methods: Total 834 chronic hepatitis B (with or without delta agent) patients were included to the study from November 2017 to June 2019. The material was collected from the regional hepatological сenters from 13 cities of Kazakhstan. Genotyping of HBV/HDV isolates was carried out using phylogenetic analysis of null-binary sequences of Kazakhstani isolates, in comparison with the reference sequences. Nucleotide sequence alignment was performed using the ClustalW algorithm, the “neighbor-joining” method was used for the construction of phylogenetic trees and subsequent analysis. Results: Overall 341 samples were PCR-positive and genotyped for HBV. Comparison and phylogenetic analysis of nucleotide sequences of HBV isolates showed that they were represented by genotypes HBV-D (95.9%), HBV-A (3.5%) and HBV-C (0.6%). At the same time, the identity of the nucleotide sequences of Kazakhstani isolates were: HBV-D (95–100%); HBV-A (97.2–100%) and HBV-C (99%). 256 samples were PCR positive and genotyped for HDV, all of them belonged to genotype 1. Conclusion: This study describes for the first time the molecular epidemiology of HBV and HDV in Kazakhstan. The data obtained expand the knowledge of the global epidemiology of viruses; have potential implications for public health policy and for further clinical research on chronic hepatitis in Kazakhstan. Trial registration: ClinicalTrials.gov NCT05095181 (registered on 27/10/2021).
30 June 2022 in Наука и здравоохранение
Background. Hepatocellular carcinoma (HCC) is the most common primary malignant neoplasm of the liver. HCC is the fifth most common cancer among men worldwide and seventh among women, and is the second leading cause of cancer deaths in the world. In Kazakhstan HCC consistently ranks 10th in the structure of oncological diseases. The aim of the research is to study the organizational and clinical features of providing care to patients with HCC at National Scientific Center of Surgery named after A.N. Syzganov. Materials and methods. Retrospective study. We studied inpatient records of patients diagnosed with HCC at National Scientific Center of Surgery named after A.N. Syzganov from 2012 to 2020. It was processed in the statistical package IBM SPSS Statistics 20. The following variables were used for the analysis: qualitative (history of diseases, stage of fibrosis) and quantitative (age, duration of hospital stay, bilirubin level, body mass index). Pearson’s chi-square test was applied to test for the difference. Chi‑squared test was used to compare the categorical or nominal variables. Differences were considered statistically significant when P ≤ 0.05. We assessed association between continuous variables total bilirubin and BMI in patients with HCC using Correlation Analysis. Results. According to the results of the study, 183 patients were treated at National Scientific Center of Surgery named after A.N. Syzganov from 2012 to 2020 (ICD-10-C22.0). The average length of hospital stay was 12 bed-days. The average age of patients with HCC was 61.67 ± 8.928 (95% CI: 59.84- 63.50). Among patients, the main reason for the development of HCC was a history of hepatitis B, C, B with a delta agent. Patients with elevated bilirubin levels have a low body mass index. Basically, in recent years, transarterial chemoembolization (TACE) is used in HCC at National Scientific Center of Surgery named after A.N. Syzganov. Conclusions. The average bed-days for the clinical-cost groups diagnosed with HCC for 2012-2020 was 12 bed-days at National Scientific Center of Surgery named after A.N. Syzganov. The study revealed a correlation between BMI and the level of bilirubin associated with the development of HCC and subsequent cell necrosis. Актуальность: Гепатоцеллюлярная карцинома (ГЦК) - наиболее частое первичное злокачественное новообразование печени. ГЦК занимает пятое место по распространенности рака среди мужчин во всем мире и седьмое место среди женщин и является второй ведущей причинойсмертности от рака в мире. В Казахстане ГЦК стабильно занимает 10-е место в структуре онкологических заболеваний. Цель исследования: изучить организационные и клинические особенности оказания помощи пациентам с печеночноклеточным раком в условиях АО «Национальный научный центр хирургии им.Сызганова». Материалы и методы исследования: Ретроспективное исследование. Для обработки и анализа были использованы стационарные карты пациентов с диагнозом “Печеночноклеточный рак” в АО «Национальный научный центр хирургии им. А.Н.Сызганова». Данные с 2012 по 2020 годы были обработаны в статистической программе IBM SPSS Statistics 20. Для анализа были использованы следующие переменные: качественные (наличие заболеваний в анамнезе, стадия фиброза) и количественые (возраст, длительность пребывания пациентов в стационаре, уровень билирубина, индекс массы тела). Для проверки разницы применялся критерий хи-квадрат Пирсона. Критерий хи-квадрат использовался для сравнения категориальных или номинальных переменных. Различия считались статистически значимыми при P≤0,05. Мы оценили связь между непрерывными переменными общего билирубина и ИМТ у пациентов с ГЦК с помощью корреляционного анализа. Результаты исследования: Согласно результатам исследования 183 пациента проходили стационарное лечение с диагнозом по МКБ-10 “С22.0 Печеночноклеточный рак” в условиях АО «Национальный научный центр хирургии им. А.Н. Сызганова» с 2012 года по 2020 год. Средняя длительность пребывания больного в стационаре составила 12 койко-дней. Средний возраст пациентов с ГЦК составил 61,67 ±8.928 (ДИ 95%: 59.84- 63.50). Среди пациентов основной причиной развития ГЦК являлось наличие в анамнезе гепатита В,С, В с дельта-агентом. У пациентов с повышенным уровнем билирубина наблюдается низкий индекс массы тела. В...